TheraTech's Andropatch is available in the UK:
This article was originally published in Clinica
TheraTech's Andropatch is available in the UK through SmithKline Beecham. The transdermal patch contains testosterone in liquid form and is used to treat testosterone-deficiency in hypogonadal men. Only available on prescription in the UK, the patch has been on the US market under the trade name Andoderm since November 1995 (see Clinica No 704, p 10). It is estimated that hypogonadism affects one in two hundred men.
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.